07 August 2020
Following on from part one, in this webinar Mathys & Squire attorneys Peter Arch and Alexander Robinson take a closer look at controversies arising from recent case law, including whether SPCs can be granted for second medical indications, and how precisely the authorised product must be identified in a patent before being eligible for an SPC.
Sign up to our mailing list to receive Mathys Matters, our monthly newsletter covering the latest IP news, industry insights, events and case law.
If you are interested in receiving quarterly newsletters relevant to our core sector groups - IT & engineering ('Inside Wires') and life sciences & chemistry ('Under the Microscope') - please select your preference(s) below:
Please select your practice area(s) of interest: